Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer

Lin, Chunlin; Lin, Penghang; Yao, Hengxin; Liu, Songyi; Lin, Xiang; He, Ruofan; Teng, Zuhong; Zuo, Xinyi; Li, Yuxuan; Ye, Jianxin; Zhu, Guangwei

doi:10.1016/j.canlet.2024.216712

Cancer Letters

2024

DOI: 10.1016/j.canlet.2024.216712

|View full text |Cite

Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer

Chunlin Lin,

Penghang Lin,

Hengxin Yao

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

Hou,

Chen,

Lei

et al. 2024

Angewandte Chemie

View full text Add to dashboard Cite

Malignant tumors pose a significant threat to global public health. Promoting programmed cell death in cancer cells has become a critical strategy for cancer treatment. PANoptosis, a newly discovered form of regulated cell death, integrates key molecular components of pyroptosis, apoptosis, and necroptosis, activating these three death pathways simultaneously to achieve synergistic multi‐mechanistic killing. PANoptosis significantly inhibits cancer cell growth and resistance, making tumor‐specific induction of PANoptosis a potential cancer therapeutic strategy. Currently, cancer treatment research related to PANoptosis is mainly focused on the development of small molecules and cytokines. However, these approaches still face limitations in terms of metabolic stability and tumor specificity. The development of nanotechnology offers new opportunities for cancer treatment by improving targeting efficiency, extending circulation time, and enhancing therapeutic efficacy and safety. Additionally, the unique physicochemical properties of nanomaterials can effectively optimize PANoptosis induction strategies, establishing nanomaterials as ideal candidates for inducing PANoptosis in tumor cells. This review summarizes the concept and mechanisms of PANoptosis, highlights the latest applications of nanoagents in PANoptosis‐based anti‐cancer therapy, and discusses the challenges and future directions for clinical translation. This review will inspire further exploration and development of PANoptosis‐based cancer treatments, providing new perspectives for researchers in the field

show abstract

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

Hou,

Chen,

Lei

et al. 2024

Angewandte Chemie

View full text Add to dashboard Cite

show abstract

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

Hou,

Chen,

Lei

et al. 2024

Angew Chem Int Ed

View full text Add to dashboard Cite

show abstract

PANoptosis: A new era for anti-cancer strategies

Cui,

Li,

et al. 2024

Life Sciences

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer

Cited by 6 publications

References 31 publications

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy

PANoptosis: A new era for anti-cancer strategies

Contact Info

Product

Resources

About